All Stories

  1. A study to assess the methodological quality of in vivo animal experiments published in Indian journal of pharmacology: A retrospective, cross-sectional, observational study
  2. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study
  3. A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India
  4. Medical Device Regulations: A Current Perspective
  5. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India
  6. A cross-sectional retrospective study to assess the pattern of prescribing for inpatient hypertensive cases in a tertiary hospital and to find out the possible avenues for betterment of hypertension management
  7. Paperless clinical trials: Myth or reality?
  8. A study on the knowledge, attitude, and the practice of generic medicines among the doctors in a tertiary care teaching hospital in South India
  9. A background to collating and using trial data
  10. Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms
  11. Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities
  12. The pattern of antihypertensive medication use among elderly patients in a tertiary care teaching hospital in South India
  13. Vaccines for Type 1 Diabetes
  14. An insight into the emerging role of regional medical advisor in the pharmaceutical industry
  15. The relevance of confidence interval and P-value in inferential statistics
  16. Use of Bayesian statistics in drug development: Advantages and challenges
  17. Intention-to-treat concept: A review
  18. Implications of ICH-E5: Assessment of drug′s sensitivity to ethnic factors and necessity of a bridging study for global drug development
  19. New therapeutic approach for latent tuberculosis infection
  20. Non-inferiority clinical trials: Practical issues and current regulatory perspective
  21. Regulatory filing strategy for generic mesalazine modified release formulations
  22. The need to develop and sustain a symbiotic relationship between the industry and academia in the field of clinical pharmacology in India
  23. Vaccines for type 1 diabetes in the late stage of clinical development